Tag: BSc

Poster-Quality of Life and Outcomes

Patient-Reported Outcome Measures in Multiple Sclerosis Clinical Trials: Critical Assessment and Insights from People Living with Multiple Sclerosis

Background: Multiple sclerosis (MS) clinical trials often include patient-reported outcomes (PROs) to quantify treatment effects not...

Read More

Poster-Rehabilitation Poster

A Scoping Review of Task-Oriented Exercise Effects on Motor Function in People with Multiple Sclerosis

Background: Exercise improves cardiorespiratory and musculoskeletal fitness for people with multiple sclerosis (MS). Recent work suggests...

Read More

Poster-Quality of Life and Outcomes

Understanding MS Symptoms and Impacts through Semi-Structured Interviews with Clinical Experts and People Living with MS

Background: Multiple sclerosis (MS) is a chronic progressive disease, affecting a broad range of important functions. In order to...

Read More

Poster-Quality of Life and Outcomes

Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis

Background: Historically, there has been limited research on care partners of patients with multiple sclerosis (MS). Employers, health care...

Read More

Poster-Neuropathology and Pathogenesis

Altered Expression of the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 (A1) Contributes to the Pathogenesis of Neurodegeneration in Multiple Sclerosis

Background: Dysfunctional RNA binding proteins (RBPs) have been shown to contribute to the pathogenesis of neurodegeneration (NDG) in...

Read More

Poster-Family and Caregivers

Parents’ Experiences of a Multiple Sclerosis (MS) Diagnosis in Their Young Adult Sons/Daughters: An Interpretative Phenomenological Study

Background: Multiple Sclerosis is the most common neurological disorder in young people, specifically across the ages of 20-40 when initial...

Read More

Poster-Disease-modifying Therapy

Alopecia in Multiple Scleoris Patients Treated with Disease Modifying Therapies

Background: There is limited literature about the frequency of alopecia in people with multiple sclerosis (MS) treated with disease...

Read More

Poster-Disease-modifying Therapy

Incidence and Severity of Natalizumab Infusion-Related Reactions during Infusion and Postinfusion Observation

Background: Natalizumab, an efficacious treatment for relapsing forms of multiple sclerosis, has an approved dosing of 300 mg infused...

Read More

Poster-Disease-modifying Therapy

Psoriasis in Multiple Sclerosis Patients Treated with Disease Modifying Therapies

Background: Psoriasis may be more common in people living with multiple sclerosis (PwMS) than in the general population. Some pathways...

Read More

Poster-Case Reports / Case Series

Treatment Resistant Tinea Corporis in Multiple Sclerosis Patients Treated with Ocrelizumab

Background: Tinea corporis is a fungal infection of the skin excluding the face, hands, feet, scalp, nail, or groin. It mostly affects the...

Read More